Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial - eBioMedicine
Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia | FDA
Schizophrenia Research | The Nathan Kline Institute for Psychiatric Research
A Novel Way to Quantify Schizophrenia Symptoms in Clinical Trials
Increasing the Precision of Cognitive Endpoints in Schizophrenia Clinical Trials - Xtalks
Schizophrenia Research | The Nathan Kline Institute for Psychiatric Research
Schizophrenia Study - CenExel CBH
NIH public-private partnership to advance early interventions for schizophrenia | National Institutes of Health (NIH)
Clinical Trials - Treatment for Patients with Schizophrenia.
Clinical trials using yokukansan for patients with schizophrenia and... | Download Table
Schizophrenia Clinical Trials | Clinical Trials GPS
Clinical Research Study on Schizophrenia | Segal Trials
$15,456 to Enroll 113 U.S Adults With Schizophrenia | Wayturn
Clinical trials testing Cannabidiol as a treatment for schizophrenia... | Download Scientific Diagram
Schizophrenia - Oklahoma City OK (Clinical Trial # 22669)
Global Schizophrenia Clinical Trial Pipeline Highlights - 2021
Practical clinical trials for schizophrenia | Epidemiology and Psychiatric Sciences | Cambridge Core
Using defined inclusion criteria to establish baseline cognitive deficits in CIAS clinical trials | Cambridge Cognition
Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial | Trials | Full Text
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial - The Lancet
Summary of Criteria Used in Clinical Trials of Treatment-Resistant... | Download Scientific Diagram
Schizophrenia Clinical Trial Solutions | Schizophrenia Endpoints & Assessments
Three ways you can design better drug trials for schizophrenia therapeutics | Cambridge Cognition
